HECTOR YE: Open Payments
NPI 1134515422 · FLUSHING, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,798 in 83 payments from 13 companies in 2025. Trend: 2023 $5,029 · 2024 $5,551 · 2025 $4,798
Food & beverage: $2,798Speaker / faculty: $2,000
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $2,777 |
| Gilead Sciences, Inc. | 23 | $533 |
| Phathom Pharmaceuticals, Inc. | 8 | $393 |
| Ipsen Biopharmaceuticals, Inc | 3 | $194 |
| Ardelyx, Inc. | 10 | $187 |
| Aimmune Therapeutics, Inc. | 4 | $185 |
| Novo Nordisk Inc | 1 | $125 |
| Viatris Specialty LLC | 1 | $125 |
| Madrigal Pharmaceuticals | 4 | $103 |
| Intercept Pharmaceuticals, Inc. | 4 | $83 |
Products named: LINZESS, VOQUEZNA, CREON, IQIRVO, IBSRELA, ZENPEP, VYALEV, Ozempic.
Industry payments across NY — which companies pay providers there.
